Liquid Crystal Bioagent Detection via Polymerized Target Membrane
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current biosensors face challenges in achieving high sensitivity and selectivity for bioagent detection, often requiring complex electronic and photonic systems, which are costly, unreliable, and consume high power, while biomolecular methods like ELISA require macro-scale spectrometry systems, limiting their practicality.
Innovation Solution
A liquid crystal device with a membrane containing a polymerized bioagent target is used, where the interaction between the bioagent and target causes an orientation change in the liquid crystal, allowing for sensitive and selective detection of bioagents like enzymes and antibodies, without the need for complex electronics or large-scale spectrometry.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If complex electronic and photonic systems are used for bioagent detection, then sensitivity and selectivity are improved, but device complexity, cost, and power consumption increase
Solution Approach 1:
The patent extracts the biorecognition function from complex electronic systems and places it directly at the interface between liquid crystal and aqueous phase. The membrane with polymerized target molecules performs specific binding at the interface, eliminating the need for integrated microelectronics and photonic systems while maintaining high sensitivity and selectivity.
Solution Approach 2:
The liquid crystal acts as an intermediary between the biorecognition event and the optical detection system. When the bioagent binds to the polymerized target at the interface, it induces orientation changes in the liquid crystal molecules, which are then easily detectable by simple optical microscopy, bridging the gap between molecular recognition and macroscopic detection.
2Measurement precision
If biomolecular methods like ELISA are used for bioagent detection, then sensitivity is improved, but the requirement for macro-scale spectrometry systems increases
Solution Approach 1:
The patent replaces the mechanical/optical complexity of macro-scale spectrometry systems with a simple optical detection method. The liquid crystal's orientation changes, induced by bioagent binding at the interface, can be detected using basic optical microscopy, eliminating the need for sophisticated spectrometry instrumentation while preserving the sensitivity of biomolecular recognition methods.
3Measurement precision
If high sensitivity detection is achieved, then detection capability is improved, but false alarms increase
Solution Approach 1:
The patent implements local quality by creating a highly specialized interface region with polymerized target molecules that are specific to the desired bioagent. This localized biorecognition structure ensures that only the specific target molecule induces orientation changes in the liquid crystal, providing high sensitivity while maintaining reliability by preventing false alarms from non-specific interactions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device provides rapid and accurate detection of bioagents with minimal false alarms, using a simple and cost-effective method that does not require extensive system integration or power-intensive electronics, enabling efficient detection of proteases, neurotoxins, and antibodies.
Implementation Method 1
Interaction of the bioagent with the polymerized target causes an orientation change in the liquid crystal thereby indicating the presence of the bioagent in the sample
Data Source
AI summary
The present invention provides liquid crystal-based devices and methods for bioagent detection. In certain aspects, the present invention is directed to devices and methods utilizing liquid crystals and membranes containing polymerized targets that can report the presence of bioagents including, but not limited to, enzymes, antibodies, and toxins.